Cargando…
Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
BACKGROUND: Schistosomiasis is responsible for a tremendous public health burden, yet only a single drug, praziquantel, is available. New antischistosomal treatments should therefore be developed. The accuracy, speed and objectivity of in vitro drug screening depend on the assay read-out. Microscopy...
Autores principales: | Panic, Gordana, Flores, Dayana, Ingram-Sieber, Katrin, Keiser, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672532/ https://www.ncbi.nlm.nih.gov/pubmed/26644133 http://dx.doi.org/10.1186/s13071-015-1233-3 |
Ejemplares similares
-
Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula
por: Marxer, Monika, et al.
Publicado: (2012) -
Role of arginase in killing of schistosomula of schistosoma mansoni
por: Olds, GR, et al.
Publicado: (1980) -
Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015) -
Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro
Publicado: (1978)